CHEMOCENTRYX INC (CCXI)
US16383L1061 - Common Stock
| TTM (2022-6-30) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | 2018 (2018-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -133.09M | -131.75M | -55.36M | -55.49M | -37.97M | |||
| Depreciation Amortization | 4.06M | 3.14M | 800.00K | 1.64M | 510.00K | |||
| Change In Working Capital | 37.92M | 16.37M | -52.96M | -26.42M | 44.13M | |||
| Interest Paid | 1.98M | 2.03M | 1.95M | 1.74M | 750.00K | |||
| Other non cash items | 37.61M | 36.62M | 26.37M | 10.14M | 9.76M | |||
| OPERATING CASH FLOW | -53.50M | -75.62M | -81.14M | -70.12M | 16.44M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -5.47M | -19.02M | -15.41M | -790.00K | -840.00K | |||
| Other Investing Activity | 18.00M | 111.24M | -266.95M | -11.74M | -52.23M | |||
| INVESTING CASH FLOW | 12.53M | 92.22M | -282.36M | -12.53M | -53.07M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | N/A | -1.05M | 4.36M | 0.00 | 14.91M | |||
| Stock Issued/Repurchased | 12.34M | 7.41M | 355.97M | 96.13M | 10.47M | |||
| Other Financing Activity | -3.13M | -5.27M | -3.71M | -1.31M | -680.00K | |||
| FINANCING CASH FLOW | 8.16M | 1.08M | 356.62M | 94.82M | 24.70M | |||
| CHANGE IN CASH | -32.81M | 17.68M | -6.88M | 12.17M | -11.93M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -53.50M | -75.62M | -81.14M | -70.12M | 16.44M | |||
| Capital Expenditure | -5.47M | -19.02M | -15.41M | -790.00K | -840.00K | |||
| FREE CASH FLOW | -58.97M | -94.64M | -96.55M | -70.91M | 15.60M | |||
All data in USD